AI | pharmaphorum

AI

Views & Analysis

Takeda’s Adam Zaeske discusses how cross-sector collaboration is shaping a brighter future for rare disease diagnosis.

Views & Analysis

As biopharmaceutical products have become increasingly complex, both in design and in regulatory requirements, we need a new way of working.

Partner Content

Partner Content

Digital

The combination of big data and artificial intelligence/machine learning is a powerful one and nowhere more so than in healthcare.

Digital

Sheila Rocchio highlights four key areas life sciences must improve on as an industry to drive real change in how clinical trials are conducted.

Views & Analysis

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations in medicine.